Regent Peak Wealth Advisors LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 77.5% during the 1st quarter, Holdings Channel reports. The firm owned 1,575 shares of the healthcare conglomerate’s stock after selling 5,427 shares during the period. Regent Peak Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $586,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in UNH. OLD Mission Capital LLC purchased a new position in UnitedHealth Group during the third quarter valued at $439,000. Schonfeld Strategic Advisors LLC purchased a new position in UnitedHealth Group during the third quarter valued at $1,055,000. Rockland Trust Co. grew its stake in shares of UnitedHealth Group by 2.9% in the 4th quarter. Rockland Trust Co. now owns 6,591 shares of the healthcare conglomerate’s stock worth $2,311,000 after buying an additional 185 shares in the last quarter. Private Trust Co. NA grew its stake in shares of UnitedHealth Group by 2.3% in the 4th quarter. Private Trust Co. NA now owns 10,829 shares of the healthcare conglomerate’s stock worth $3,797,000 after buying an additional 240 shares in the last quarter. Finally, First National Bank of Mount Dora Trust Investment Services grew its stake in shares of UnitedHealth Group by 1.3% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 12,717 shares of the healthcare conglomerate’s stock worth $4,460,000 after buying an additional 169 shares in the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.
A number of equities analysts have commented on UNH shares. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $410.00 to $435.00 and gave the stock a “market perform” rating in a research note on Thursday, April 22nd. Truist Securities lifted their price target on shares of UnitedHealth Group from $420.00 to $450.00 and gave the stock a “buy” rating in a research note on Tuesday, April 20th. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $415.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, April 22nd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $409.00 to $418.00 and gave the company a “buy” rating in a report on Thursday, April 22nd. Finally, Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 price objective for the company in a report on Tuesday, April 27th. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $409.61.
NYSE:UNH traded up $4.20 during trading hours on Tuesday, hitting $410.10. 51,442 shares of the company were exchanged, compared to its average volume of 3,262,127. The company’s 50 day moving average price is $378.48 and its 200-day moving average price is $349.25. The stock has a market capitalization of $387.09 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.55 and a beta of 0.74. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. UnitedHealth Group Incorporated has a 52-week low of $273.71 and a 52-week high of $406.77.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Wednesday, April 14th. The healthcare conglomerate reported $5.31 EPS for the quarter, beating the consensus estimate of $4.38 by $0.93. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The business had revenue of $70.20 billion for the quarter, compared to the consensus estimate of $69.13 billion. During the same period in the prior year, the firm earned $3.72 EPS. The business’s revenue for the quarter was up 9.0% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date was Friday, March 12th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.09%.
In other UnitedHealth Group news, EVP Patricia L. Lewis sold 3,000 shares of the company’s stock in a transaction on Friday, April 16th. The shares were sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the completion of the transaction, the executive vice president now directly owns 9,214 shares in the company, valued at $3,593,367.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 5,301 shares of the company’s stock in a transaction on Tuesday, April 27th. The stock was sold at an average price of $394.66, for a total transaction of $2,092,092.66. Following the transaction, the chief accounting officer now owns 58,589 shares of the company’s stock, valued at $23,122,734.74. The disclosure for this sale can be found here. Insiders have sold 20,420 shares of company stock worth $7,532,962 over the last three months. 0.80% of the stock is currently owned by insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Featured Article: What is the downside to momentum investing?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.